American Vanguard (NYSE:AVD) Director Steven Macicek Acquires 19,000 Shares of Stock

Posted by Geri Gentry on Aug 18th, 2026

American Vanguard Corporation (NYSE:AVD – Get Free Report) Director Steven Macicek purchased 19,000 shares of the company’s stock in a transaction on Monday, August 17th. The shares were purchased at an average cost of $2.09 per share, with a total value of $39,710.00. Following the purchase, the director owned 99,711 shares of the company’s stock, valued at approximately $208,395.99. The trade was a 23.54% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

American Vanguard Price Performance

Shares of AVD traded down $0.04 during midday trading on Tuesday, reaching $2.19. The stock had a trading volume of 1,720,856 shares, compared to its average volume of 324,210. The company has a current ratio of 2.47, a quick ratio of 1.40 and a debt-to-equity ratio of 1.46. The company has a market capitalization of $64.75 million, a price-to-earnings ratio of -1.16 and a beta of 1.43. The company’s 50-day moving average is $2.62 and its 200 day moving average is $3.17. American Vanguard Corporation has a 12-month low of $2.03 and a 12-month high of $5.92.

American Vanguard (NYSE:AVD – Get Free Report) last announced its quarterly earnings data on Monday, August 10th. The basic materials company reported ($0.34) earnings per share for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.43). The firm had revenue of $116.75 million for the quarter, compared to analysts’ expectations of $135.00 million. American Vanguard had a negative net margin of 10.70% and a negative return on equity of 9.05%.

Hedge Funds Weigh In On American Vanguard

Institutional investors and hedge funds have recently bought and sold shares of the stock. Wellington Management Group LLP increased its stake in American Vanguard by 4.4% in the 4th quarter. Wellington Management Group LLP now owns 1,700,161 shares of the basic materials company’s stock worth $6,495,000 after purchasing an additional 71,632 shares during the period. BlackRock Inc. purchased a new stake in shares of American Vanguard during the second quarter valued at approximately $2,614,000. Geode Capital Management LLC grew its holdings in shares of American Vanguard by 2.2% in the second quarter. Geode Capital Management LLC now owns 639,301 shares of the basic materials company’s stock worth $2,506,000 after purchasing an additional 13,657 shares during the last quarter. EVR Research LP grew its holdings in shares of American Vanguard by 82.0% in the fourth quarter. EVR Research LP now owns 618,657 shares of the basic materials company’s stock worth $2,363,000 after purchasing an additional 278,657 shares during the last quarter. Finally, Potomac Capital Management Inc. purchased a new position in shares of American Vanguard in the fourth quarter worth $1,751,000. 79.00% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

AVD has been the subject of a number of recent research reports. Wall Street Zen lowered shares of American Vanguard from a “hold” rating to a “sell” rating in a report on Saturday. Weiss Ratings reiterated a “sell (e+)” rating on shares of American Vanguard in a research report on Thursday. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has a consensus rating of “Sell”.

Check Out Our Latest Report on American Vanguard

About American Vanguard

(Get Free Report)

American Vanguard Corporation (NYSE: AVD) is a developer, manufacturer and marketer of specialty chemical products for crop protection, turf and ornamental care, and public health pest control. Headquartered in Newport Beach, California, the company offers a portfolio of insecticides, herbicides, fungicides and rodenticides designed for use across agricultural, turf and urban pest management applications. Its research and development efforts focus on novel chemistries and formulation technologies that address emerging pest resistance and regulatory requirements.

The company’s product lines include emulsifiable concentrates, wettable powders, granular formulations, baits and liquid concentrates sold under proprietary brand names.